TrialJAMA oncology2022

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer: The REALITY Randomized Clinical Trial.

Yansong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.